一例与钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂相关的正常血糖性糖尿病酮症酸中毒病例。
A Case of Euglycemic Diabetic Ketoacidosis Associated With a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
作者信息
Hedary Antoine, Melder Lacie, Pippin Micah
机构信息
Family Medicine, Louisiana State University Health Sciences Center, Alexandria, USA.
出版信息
Cureus. 2024 Dec 9;16(12):e75399. doi: 10.7759/cureus.75399. eCollection 2024 Dec.
Abstract
Euglycemic diabetic ketoacidosis is a rare metabolic derangement seen in both type 1 and type 2 diabetes. Initially characterized decades ago, the prevalence of euglycemic diabetic ketoacidosis has increased in recent years following the introduction of sodium-glucose cotransporter-2 (SGLT2) inhibitors. Here, we present a case of euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors.
摘要
正常血糖性糖尿病酮症酸中毒是1型和2型糖尿病中均可见的一种罕见代谢紊乱。几十年前首次被描述，近年来随着钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的应用，正常血糖性糖尿病酮症酸中毒的患病率有所增加。在此，我们报告一例与SGLT2抑制剂相关的正常血糖性糖尿病酮症酸中毒病例。
Zotero 插件